These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Stable chronic obstructive pulmonary disease. Published correction for one of studies must be borne in mind. Poole P; Black P BMJ; 2000 Jan; 320(7230):312-3. PubMed ID: 10722291 [No Abstract] [Full Text] [Related]
23. [Other drugs (not bronchodilators) in COPD]. García Río F Arch Bronconeumol; 2004 Mar; 40 Suppl 1():34-40. PubMed ID: 16137448 [No Abstract] [Full Text] [Related]
24. [N-Acetylcysteine: low and high doses in the treatment of chronic obstructive lung diseases in Chernobyl accident liquidators]. Chikina SIu; Iagmurov BKh; Kopylev ID; Soodaeva SK; Chuchalin AG Ter Arkh; 2002; 74(3):62-5. PubMed ID: 11980127 [TBL] [Abstract][Full Text] [Related]
25. Oxidation pathway and exacerbations in COPD: the role of NAC. Matera MG; Calzetta L; Cazzola M Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752 [TBL] [Abstract][Full Text] [Related]
27. De medicamenteuze behandeling van chronisch obstructieve longziekte [Drug treatment of chronic obstructive lung disease. Cabolet P Ned Tijdschr Geneeskd; 1996 Aug; 140(33):1705. PubMed ID: 8776959 [No Abstract] [Full Text] [Related]
28. [Current broncholytic and expectorant therapy of patients with chronic nonspecific lung diseases]. Solopov VN; Kolganova NA; Chuchalin AG Ter Arkh; 1987; 59(12):96-9. PubMed ID: 2965833 [TBL] [Abstract][Full Text] [Related]
29. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo. Verstraeten JM Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153 [No Abstract] [Full Text] [Related]
30. Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs. Chest; 1994 Nov; 106(5):1532-7. PubMed ID: 7956415 [No Abstract] [Full Text] [Related]
31. [Expectorants, antitussive agents, bronchospasmolytic agents. Therapy of obstructive respiratory tract diseases]. Haen E Med Monatsschr Pharm; 1989 Nov; 12(11):344-55. PubMed ID: 2685526 [No Abstract] [Full Text] [Related]
35. N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Gerrits CM; Herings RM; Leufkens HG; Lammers JW Eur Respir J; 2003 May; 21(5):795-8. PubMed ID: 12765423 [TBL] [Abstract][Full Text] [Related]
36. [Broncholytic and cardiocirculatory effect of methylephedrine and ephedrine]. Gregori P Z Gesamte Inn Med; 1972 Dec; 27(24):1093-7. PubMed ID: 4631892 [No Abstract] [Full Text] [Related]
38. Mucoactive drugs in the management of chronic obstructive pulmonary disease. Del Donno M; Olivieri D Monaldi Arch Chest Dis; 1998 Dec; 53(6):714-9. PubMed ID: 10063352 [TBL] [Abstract][Full Text] [Related]
39. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Dekhuijzen PN Eur Respir J; 2004 Apr; 23(4):629-36. PubMed ID: 15083766 [TBL] [Abstract][Full Text] [Related]
40. [Acetylcysteine in children with lung disorders prescribed by one third of family physicians; no support in the literature]. Dekhuijzen PN Ned Tijdschr Geneeskd; 1997 Aug; 141(31):1542. PubMed ID: 9543745 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]